| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
American Journal of Pathology, Vol 142, 1335-1338, Copyright © 1993 by American Society for Investigative Pathology
REGULAR ARTICLES |
TR Ulich, S Yin, DG Remick, D Russell, SP Eisenberg and T Kohno
Department of Pathology, UC San Diego School of Medicine 921030.
Endotoxin lipopolysaccharide (LPS) administered intratracheally to rats causes pulmonary tumor necrosis factor alpha (TNF) and interleukin-1 (IL-1) production and results in acute broncho-alveolar neutrophilic inflammation. In the present study, the recombinant human TNF soluble receptor type I (sTNFrI) co-injected intratracheally with LPS is shown to inhibit significantly (P < 0.0001) the number of neutrophils in bronchoalveolar lavage specimens at 6 hours as compared to intratracheal injection of LPS alone. The sTNFrI was at least as effective as the recombinant human IL-1 receptor antagonist (IL-1ra) as an inhibitor of acute inflammation. Inhibition of LPS-induced acute inflammation by the combination of sTNFrI and IL-1ra was not significantly more than the inhibition afforded by sTNFrI alone. Intratracheal co-injection of sTNFrI with LPS unexpectedly increased TNF levels in BAL specimens, perhaps by changing the normal catabolism of TNF. On the other hand, co-injection of sTNFrI and LPS decreased IL- 6 levels in BAL fluid, most likely by interfering with the induction of IL-6 by TNF. The sTNFrI may prove to be an important pharmacological down-regulator of acute inflammation.
This article has been cited by other articles:
![]() |
J.-H. Lee, L. Del Sorbo, A. A. Khine, J. de Azavedo, D. E. Low, D. Bell, S. Uhlig, A. S. Slutsky, and H. Zhang Modulation of Bacterial Growth by Tumor Necrosis Factor-{alpha} In Vitro and In Vivo Am. J. Respir. Crit. Care Med., December 15, 2003; 168(12): 1462 - 1470. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. C. Leemans, M. Heikens, K. P. M. van Kessel, S. Florquin, and T. van der Poll Lipoteichoic Acid and Peptidoglycan from Staphylococcus aureus Synergistically Induce Neutrophil Influx into the Lungs of Mice Clin. Vaccine Immunol., September 1, 2003; 10(5): 950 - 953. [Abstract] [Full Text] [PDF] |
||||
![]() |
E.-B. Haddad, K. McCluskie, M. A. Birrell, D. Dabrowski, M. Pecoraro, S. Underwood, B. Chen, G. T. De Sanctis, S. E. Webber, M. L. Foster, et al. Differential Effects of Ebselen on Neutrophil Recruitment, Chemokine, and Inflammatory Mediator Expression in a Rat Model of Lipopolysaccharide-Induced Pulmonary Inflammation J. Immunol., July 15, 2002; 169(2): 974 - 982. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Beckmann, B. Tigani, R. Sugar, A. D. Jackson, G. Jones, L. Mazzoni, and J. R. Fozard Noninvasive detection of endotoxin-induced mucus hypersecretion in rat lung by MRI Am J Physiol Lung Cell Mol Physiol, July 1, 2002; 283(1): L22 - L30. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Corbel, N. Germain, J. Lanchou, S. Molet, P. M. R. e Silva, M. A. Martins, E. Boichot, and V. Lagente The Selective Phosphodiesterase 4 Inhibitor RP 73-401 Reduced Matrix Metalloproteinase 9 Activity and Transforming Growth Factor-beta Release During Acute Lung Injury in Mice: The Role of the Balance Between Tumor Necrosis Factor-alpha and Interleukin-10 J. Pharmacol. Exp. Ther., April 1, 2002; 301(1): 258 - 265. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. W. Rijneveld, S. Florquin, J. Branger, P. Speelman, S. J. H. Van Deventer, and T. van der Poll TNF-{alpha} Compensates for the Impaired Host Defense of IL-1 Type I Receptor-Deficient Mice During Pneumococcal Pneumonia J. Immunol., November 1, 2001; 167(9): 5240 - 5246. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. P. JUFFERMANS, A. VERBON, J. T. BELISLE, P. J. HILL, P. SPEELMAN, S. J. H. van DEVENTER, and T. van der POLL Mycobacterial Lipoarabinomannan Induces an Inflammatory Response in the Mouse Lung . A Role for Interleukin-1 Am. J. Respir. Crit. Care Med., August 1, 2000; 162(2): 486 - 489. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Kato, Y. Kato, K. Takeuchi, and I. Nakashima Local Levels of Soluble Tumor Necrosis Factor Receptors in Patients With Allergic Rhinitis Are Regulated by Amount of Antigen Arch Otolaryngol Head Neck Surg, August 1, 2000; 126(8): 997 - 1000. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Panoskaltsis-Mortari, D. H. Ingbar, P. Jung, I. Y. Haddad, P. B. Bitterman, O. D. Wangensteen, C. L. Farrell, D. L. Lacey, and B. R. Blazar KGF pretreatment decreases B7 and granzyme B expression and hastens repair in lungs of mice after allogeneic BMT Am J Physiol Lung Cell Mol Physiol, May 1, 2000; 278(5): L988 - L999. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Fan, A. Kapus, Y. H. Li, S. Rizoli, J. C. Marshall, and O. D. Rotstein Priming for Enhanced Alveolar Fibrin Deposition after Hemorrhagic Shock . Role of Tumor Necrosis Factor Am. J. Respir. Cell Mol. Biol., April 1, 2000; 22(4): 412 - 421. [Abstract] [Full Text] |
||||
![]() |
J. P. Mizgerd, J. J. Peschon, and C. M. Doerschuk Roles of Tumor Necrosis Factor Receptor Signaling during Murine Escherichia coli Pneumonia Am. J. Respir. Cell Mol. Biol., January 1, 2000; 22(1): 85 - 91. [Abstract] [Full Text] |
||||
![]() |
T. S. Blackwell, L. H. Lancaster, T. R. Blackwell, A. Venkatakrishnan, and J. W. Christman Differential NF-kappa B activation after intratracheal endotoxin Am J Physiol Lung Cell Mol Physiol, October 1, 1999; 277(4): L823 - L830. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. J. Skerrett, T. R. Martin, E. Y. Chi, J. J. Peschon, K. M. Mohler, and C. B. Wilson Role of the type 1 TNF receptor in lung inflammation after inhalation of endotoxin or Pseudomonas aeruginosa Am J Physiol Lung Cell Mol Physiol, May 1, 1999; 276(5): L715 - L727. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Smith, S. J. Skerrett, E. Y. Chi, M. Jonas, K. Mohler, and C. B. Wilson The locus of tumor necrosis factor-alpha action in lung inflammation. Am. J. Respir. Cell Mol. Biol., December 1, 1998; 19(6): 881 - 891. [Abstract] [Full Text] |
||||
![]() |
M. F. Taylor, J. D. Paulauskis, D. D. Weller, and L. Kobzik In Vitro Efficacy of Morpholino-modified Antisense Oligomers Directed against Tumor Necrosis Factor-alpha mRNA J. Biol. Chem., July 19, 1996; 271(29): 17445 - 17452. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |